AI products from Cadence and Limbic are among four devices recently accepted into the FDA’s TEMPO pilot that will allow ...

Two recipients of gene-edited pig kidneys have successfully received human organs, a milestone in the wider effort to advance ...

Ultragenyx drug fails pivotal Phase 3, FDA's success at regulating unproven stem cells, and other biotech news ...

Tactical athletes, a category of people first recognized in the early 2000s, also need distinct kinds of health care.

Seventeen states sued the Department of Health and Human Services in 2024, alleging that a landmark disability law was ...

At a "practice of last resort," pediatricians prioritize allaying parents' vaccine concerns without hardline dismissals.

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health ...

Experts agreed that the biggest threat to progress on overdose deaths is the looming Medicaid cuts. Researchers at Penn’s ...

Ionis Pharmaceuticals on Thursday received Food and Drug Administration approval for the first disease modifying therapy for Alexander disease, a rare and deadly neurological condition.

For now, though, perhaps some headlines will suffice …  An experimental gene therapy for Angelman syndrome from Ultragenyx failed in a Phase 3 study, STAT reports. The medicine showed no benefit ...

Anthony Fauci is working on a book, we unpack Trump's latest drug pricing deals, and more from STAT's D.C. Diagnosis newsletter.

The next DSM and the algorithm, an unexpected discovery on alpha-gal syndrome, and more health news from Morning Rounds ...